Simard John's Form 4 filing
XBiotech Inc. (XBIT) · filed Feb 15, 2022
- Accession no.
- 0001209191-22-009745
- Filed
- Feb 15, 2022
- Trade date
- Oct 15-18, 2021
- Filing delay
- 123 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $657.8K. It was filed 123 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simard JohnCIK 0001639078 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 | Common Stock | SSaleDisposed | −17,000 | $13.32 | −$226,440 | 3,856,166 | Direct | |
| Oct 18, 2021 | Common Stock | SSaleDisposed | −33,000 | $13.07 | −$431,310 | 3,823,166 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.